Trader’s Recap: Progenics Pharmaceuticals (NASDAQ:PGNX), PharmAthene (NYSEMKT:PIP), Ducommun Inc. (NYSE:DCO), Agilysys Inc. (NASDAQ:AGYS), Mindray Medical International Limited (NYSE:MR)


On Wednesday shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) closed at $5.53. Company’s sales growth for last 5 years was -1.90% and EPS growth for next 5 years is recorded as 25.00%. Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) on Wednesday reported a loss of $10.3 million in its first quarter. The Tarrytown, New York-based company said it had a loss of 15 cents per share.

PharmAthene, Inc. (NYSEMKT:PIP) in last trading activity decreased -2.52% to close at $1.55. Company weekly performance is -3.55% while its quarterly performance stands at -7.19%. PharmAthene, Inc. (NYSEMKT:PIP) is -40.15% away from its 52 week high.

On last trading day Ducommun Inc. (NYSE:DCO) moved up 0.46% to close at $30.46. Its volatility for the week is 2.91% while volatility for the month is 4.63%. DCO’s sales growth for past 5 years was 11.50% and its EPS growth for past 5 years was 13.00%. Ducommun Inc. (NYSE:DCO) monthly performance is 14.86%. Zacks reaffirmed their hold rating on shares of Ducommun (NYSE:DCO) in a report released on Friday.

Agilysys Inc. (NASDAQ:AGYS) has 2.40% insider ownership while its institutional ownership stands at 84.60%. In last trading activity company’s stock closed at $8.75. Agilysys Inc. (NASDAQ:AGYS) announced results of operations for the first quarter ended March 31, 2015. Net loss for the quarter was $10.3 million or $0.15 diluted per share, compared to net loss of $9.3 million or $0.15 diluted per share in the 2014 period. Progenics ended the quarter with cash and cash equivalents of $108.4 million, a decrease of $10.9 million in the quarter.

On last trading day Mindray Medical International Limited (NYSE:MR) decreased -0.06% to close at $31.14. Its volatility for the week is 1.65% while volatility for the month is 2.41%. MR’s sales growth for past 5 years was 15.80% and its EPS growth for past 5 years was 5.80%. Mindray Medical International Limited (NYSE:MR) monthly performance is 8.43%.Mindray Medical International Limited (NYSE:MR), announced that it will report its financial results for the first quarter ended Mar 31, 2015 after the U.S. market closes on May 11, 2015.


Leave a Reply

Your email address will not be published. Required fields are marked *